News

Solvotrin Announces Long-Term Licensing Agreement with Norwell Consumer Healthcare

News

Solvotrin Announces Long-Term Licensing Agreement with Norwell Consumer Healthcare

by Ciara Barrett on Sep 01 2025
Solvotrin Therapeutics, a leading Irish healthcare development company, is delighted to announce the signing of a long-term licensing agreement with Norwell Consumer Healthcare for the Active Iron brand in Canada.
Solvotrin Therapeutics Announces Exclusive Agreement with Ortho Molecular Products

News

Solvotrin Therapeutics Announces Exclusive Agreement with Ortho Molecular Products

by Claire Lynch on Sep 01 2025
Solvotrin Therapeutics, a leading Irish healthcare development company, is pleased to announce an exclusive agreement with Ortho Molecular Products for the distribution of Active Iron in the U.S. practitioner channel.